FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2171018445> ?p ?o ?g. }

• W2171018445 endingPage "170" @default.
• W2171018445 startingPage "170" @default.
• W2171018445 abstract "Urachal carcinoma is a rare tumor that is usually associated with a poor prognosis, especially the pathological type, urachal mucinous adenocarcinoma. Surgery remains the primary treatment in prolonging the overall survival time of patients. We report on a 41-year-old woman with urachal mucinous adenocarcinoma who underwent three surgeries and several courses of chemotherapy over a 42-month period. The first surgery, involving en-bloc excision of the urachal mass, partial urinary bladder, urachal ligament, and umbilicus was performed in May 2007. It is well known that the correct surgical scheme plays a key role in preventing recurrence or metastasis. However, a second debulking surgery with only a single salpingo-oophorectomy may have contributed directly to the patient’s subsequent left ovarian metastasis. Therefore, we strongly recommend performing a bilateral salpingo-oophorectomy once ovarian metastasis has been detected, even if the metastasis is only present on one side. Although postoperative adjuvant chemotherapy regimens, first with Taxol, carboplatin, gemcitabine, and cisplatin, and then with IFO, EPI, and mesna were consecutively administered after the first and second surgeries, they seemed less effective, since recurrence and metastasis occurred shortly after each surgical treatment. After a third debulking surgery in June 2009, docetaxel, oxaliplatin, and capecitabine were administered. This chemotherapy regimen was chosen based on an immunohistochemical test that involved the multidrug resistance gene; this test indicated that the urachal mucinous adenocarcinoma was resistant to the two chemotherapy regimens used previously. Surprisingly, the patient exhibited a marker response to the new regimen and the metastatic foci entered into a stable disease stage. However, the patient still died of diffuse metastatic disease 1.5 years later. During the whole period of treatment, we found that serum tumor markers including CA724, CA125, CA19-9, and CEA were elevated in a linear pattern, with parallel increases in line with peritoneal carcinomatosis and parallel reductions in line with response to personalized chemotherapy. Personalized treatment can be given to those patients who experience a poor response to initial therapy. Moreover, an immunohistochemical test for the multidrug resistance gene and serum tumor markers may supply key information in the choice of reasonable chemotherapeutics." @default.
• W2171018445 created "2016-06-24" @default.
• W2171018445 creator A5035843450 @default.
• W2171018445 creator A5059331575 @default.
• W2171018445 date "2013-01-01" @default.
• W2171018445 modified "2023-10-16" @default.
• W2171018445 title "Surgical and chemotherapeutic experience regarding a urachal carcinoma with repeated relapse: case report and literature review" @default.
• W2171018445 cites W1546459744 @default.
• W2171018445 cites W1557228596 @default.
• W2171018445 cites W1969608385 @default.
• W2171018445 cites W1970611943 @default.
• W2171018445 cites W1985102748 @default.
• W2171018445 cites W1990968683 @default.
• W2171018445 cites W1995538445 @default.
• W2171018445 cites W2008087900 @default.
• W2171018445 cites W2011556797 @default.
• W2171018445 cites W2012009298 @default.
• W2171018445 cites W2032454374 @default.
• W2171018445 cites W2039530231 @default.
• W2171018445 cites W2043611830 @default.
• W2171018445 cites W2045481966 @default.
• W2171018445 cites W2048890898 @default.
• W2171018445 cites W2074884346 @default.
• W2171018445 cites W2077126261 @default.
• W2171018445 cites W2077970060 @default.
• W2171018445 cites W2080136333 @default.
• W2171018445 cites W2093179652 @default.
• W2171018445 cites W2099598655 @default.
• W2171018445 cites W2128963581 @default.
• W2171018445 cites W2152419037 @default.
• W2171018445 cites W2157670918 @default.
• W2171018445 doi "https://doi.org/10.1186/1477-7819-11-170" @default.
• W2171018445 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3765469" @default.
• W2171018445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23914849" @default.
• W2171018445 hasPublicationYear "2013" @default.
• W2171018445 type Work @default.
• W2171018445 sameAs 2171018445 @default.
• W2171018445 citedByCount "18" @default.
• W2171018445 countsByYear W21710184452016 @default.
• W2171018445 countsByYear W21710184452017 @default.
• W2171018445 countsByYear W21710184452018 @default.
• W2171018445 countsByYear W21710184452019 @default.
• W2171018445 countsByYear W21710184452020 @default.
• W2171018445 countsByYear W21710184452021 @default.
• W2171018445 countsByYear W21710184452022 @default.
• W2171018445 countsByYear W21710184452023 @default.
• W2171018445 crossrefType "journal-article" @default.
• W2171018445 hasAuthorship W2171018445A5035843450 @default.
• W2171018445 hasAuthorship W2171018445A5059331575 @default.
• W2171018445 hasBestOaLocation W21710184451 @default.
• W2171018445 hasConcept C121608353 @default.
• W2171018445 hasConcept C126322002 @default.
• W2171018445 hasConcept C141071460 @default.
• W2171018445 hasConcept C143998085 @default.
• W2171018445 hasConcept C2775910329 @default.
• W2171018445 hasConcept C2776694085 @default.
• W2171018445 hasConcept C2778239845 @default.
• W2171018445 hasConcept C2779013556 @default.
• W2171018445 hasConcept C2780352672 @default.
• W2171018445 hasConcept C2780427987 @default.
• W2171018445 hasConcept C2780962732 @default.
• W2171018445 hasConcept C2781100745 @default.
• W2171018445 hasConcept C2781190966 @default.
• W2171018445 hasConcept C2781413609 @default.
• W2171018445 hasConcept C2781451048 @default.
• W2171018445 hasConcept C526805850 @default.
• W2171018445 hasConcept C71924100 @default.
• W2171018445 hasConceptScore W2171018445C121608353 @default.
• W2171018445 hasConceptScore W2171018445C126322002 @default.
• W2171018445 hasConceptScore W2171018445C141071460 @default.
• W2171018445 hasConceptScore W2171018445C143998085 @default.
• W2171018445 hasConceptScore W2171018445C2775910329 @default.
• W2171018445 hasConceptScore W2171018445C2776694085 @default.
• W2171018445 hasConceptScore W2171018445C2778239845 @default.
• W2171018445 hasConceptScore W2171018445C2779013556 @default.
• W2171018445 hasConceptScore W2171018445C2780352672 @default.
• W2171018445 hasConceptScore W2171018445C2780427987 @default.
• W2171018445 hasConceptScore W2171018445C2780962732 @default.
• W2171018445 hasConceptScore W2171018445C2781100745 @default.
• W2171018445 hasConceptScore W2171018445C2781190966 @default.
• W2171018445 hasConceptScore W2171018445C2781413609 @default.
• W2171018445 hasConceptScore W2171018445C2781451048 @default.
• W2171018445 hasConceptScore W2171018445C526805850 @default.
• W2171018445 hasConceptScore W2171018445C71924100 @default.
• W2171018445 hasIssue "1" @default.
• W2171018445 hasLocation W21710184451 @default.
• W2171018445 hasLocation W21710184452 @default.
• W2171018445 hasLocation W21710184453 @default.
• W2171018445 hasLocation W21710184454 @default.
• W2171018445 hasOpenAccess W2171018445 @default.
• W2171018445 hasPrimaryLocation W21710184451 @default.
• W2171018445 hasRelatedWork W181704052 @default.
• W2171018445 hasRelatedWork W2048946840 @default.
• W2171018445 hasRelatedWork W2348977736 @default.
• W2171018445 hasRelatedWork W2363247478 @default.
• W2171018445 hasRelatedWork W2394421148 @default.
• W2171018445 hasRelatedWork W2597046942 @default.
• W2171018445 hasRelatedWork W2945662040 @default.

• next